The PREHAAAB Trial: Multimodal Prehabilitation for Patients Awaiting Open Abdominal Aortic Aneurysm Repair
- Conditions
- Abdominal Aortic Aneurysm
- Interventions
- Behavioral: Multimodal Prehabilitation
- Registration Number
- NCT05756283
- Lead Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Brief Summary
An abdominal aortic aneurysm is a condition where the major artery in the abdomen becomes larger than usual. Over time, as it continues to grow, the wall of the artery weakens and there is a risk that the artery can burst causing internal bleeding and death. Aortic aneurysms are fixed when they reach a certain size to prevent that outcome. The surgery to fix them is a major, high-risk surgery that is associated with a lot of complications and a slow recovery back to normal. The time between diagnosis and surgery is called the pre-operative period and is a key time to optimize a patient's health in order to ensure the best possible outcomes following surgery. This study will look at whether a multidisciplinary pre-operative program that involves exercise training, nutritional advice and supplementation, and psychosocial support will reduce complications following surgery. This program should decrease complications and speed up a patient's recovery back to normal after surgery. It is also a way for patients to take ownership of their disease and play an active role in their health care journey. The benefits from this program will go beyond the pre-operative time frame, as the habits and knowledge gained will improve their health over their lifetime. This study will also assess the economic impact and cost of a program like this.
- Detailed Description
Abdominal aortic aneurysms (AAA) are asymptomatic until they rupture, which carries an 80- 90% mortality. Therefore, AAA are surgically repaired when they reach 5.0 cm in women and 5.5cm in men. Despite advances to surgical technique and peri-operative care, open surgical repair still carries a high incidence of post-operative complications of 30-40%, and a long recovery period. This is largely because the surgery itself is major abdominal surgery, and these patients often have significant comorbidities and low functional status. Multimodal prehabilitation (MP) is a concept that uses the preoperative timeframe (between diagnosis and surgery) to optimize physical, nutritional, and emotional wellbeing to improve a patient's functional status and ability to withstand the stress of surgery. To date, there is no study evaluating the effect of MP on post-operative complications following open AAA repair.
The primary objective of this trial is to determine if MP will decrease complications as measured by the comprehensive complication index following open AAA repair compared to standard of care. This trial will also assess the effect of MP on functional capacity, hospital length of stay, 30-day mortality and health related quality of life, as well as to assess cost effectiveness, adherence, and fidelity to the intervention.
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 152
- Participants older than 50 years of age awaiting elective open AAA repair with AAA diameter ≤6.9cm. Participants should have the ability to give informed consent.
- Participants undergoing thoracic, thoracoabdominal and/or perivisceral AAA repair.
- Participants with ruptured or symptomatic AAA.
- Participants with AAA maximal diameter ≥7cm.
- Physical inability to exercise: severe osteoarthritis, musculoskeletal or neurological impairment that precludes exercise.
- Contraindication to exercise: rest systolic blood pressure ≥ 180 mmHg and/or diastolic ≥ 100 mmHg, uncontrolled atrial or ventricular arrythmias or proven exercise induced arrhythmias, unstable angina, unstable or acute heart failure, severe symptomatic valvular stenosis, dynamic left ventricular outflow tract obstruction or other comorbidities that imply clinical instability.
- Cognitive impairment that would impede understanding of study procedures, informed consent or study questionnaires or the inability to effectively communicate in English/French/Spanish/Catalan.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Multimodal Prehabilitation Multimodal Prehabilitation Participants in the intervention group will undergo, in addition to the standard of care, 6+/-1 weeks of a personalized multimodal prehabilitation program. The interventions included will be patient-centered, aiming to optimize patients' preoperative health status while enhancing their empowerment and engagement.
- Primary Outcome Measures
Name Time Method Postoperative complications measured by the Comprehensive Complication Index (CCI) CCI will be measured from admission to 6 weeks postoperatively The CCI was developed to address some of the limitations of traditional surgical morbidity reporting, such as only reporting the most severe complication or only picking the most common types of complications. It is scored on a true linear interval scale from 0-100 and incorporates the totality of all complications and their severity experienced by a patient
- Secondary Outcome Measures
Name Time Method Reinterventions from surgery day to 6 week postoperatively Need for surgical reintervention due to surgical complications
6-Minute Walk Test Measured at baseline, preoperatively and 6 weeks postoperatively 6-minute walk test
Anxiety Measured at baseline, preoperatively, 6 weeks and 1 year postoperatively Anxiety measured by the Hospital Anxiety and Depression questionnaire (HADS) 0 (no anxiety)- 21 (maximal anxiety)
Hospital length of stay From admission to 6 weeks postoperatively Days from admission to discharge from the hospital
Readmission at 6 weeks and at 1 year postoperatively Readmission to the hospital
VE/VCO2 Measured at baseline and preoperatively Minute ventilation/carbon dioxide production
SF36 Measured at baseline, preoperatively, 6 weeks and 1 year postoperatively Quality of life questionnaire
Patient Generated Subjective Global Assessment (PG-SGA) Measured at baseline, preoperatively Malnutrition assessment tool
Height Measured at baseline and preoperatively measurement of height in meters
Weight Measured at baseline and preoperatively measurement of Weight in kg
Body Fat percentage Measured at baseline and preoperatively Measurement of body fat percentage using Bioelectrical Impedance Analysis
Muscle Mass Measured at baseline and preoperatively Measurement of muscle mass in kg, using Bioelectrical Impedance Analysis
ICU Length of stay From admission to 6 weeks postoperatively Intensive Care Unit length of stay
VO2 peak Measured at baseline and preoperatively Oxygen consumption at peak exercise
Yale physical activity survey (YPAS) Measured at baseline, preoperatively, 6 weeks and 1 year postoperatively Questionnaire of daily physical activity
Compliance to intervention Measured from baseline to preoperatively Compliance to the different components of the intervention, measured by attendance to supervised sessions (%), adherence to nutritional counseling and supplementation (%), adherence to home-based exercise (%) and adherence to the psychosocial sessions (%)
Fidelity to exercise intervention Measured from baseline to preoperatively Real training wattage and kg vs expected
Body Mass Index (BMI) Measured at baseline and preoperatively Measurement of body mass index (weight and height will be combined to report BMI in kg/m\^2)
Satisfaction and acceptability Preoperative assessment Intervention satisfaction and acceptability questionnaire
Quality adjusted life years Measured at baseline, preoperatively, 6 weeks and 1 year postoperatively Quality adjusted life years derived from SF36 data (SF6D)
Emergency Room visits at 6 weeks and at 1 year postoperatively Visits to the emergency room with or without admission to the hospital
VO2 AT Measured at baseline and preoperatively Oxygen consumption at anaerobic Threshold
Incidents of adverse events (prehabilitation safety and tolerability) Measured from Baseline to Preoperatively Incidence of adverse events and severe adverse events during prehabilitation program
Depression Measured at baseline, preoperatively, 6 weeks and 1 year postoperatively Depression measured by the Hospital Anxiety and Depression questionnaire (HADS) 0 (no depression)- 21 (maximal depression)
Fat Free Mass (FFM) Measured at baseline and preoperatively Measurement of body fa free mass in kg, using Bioelectrical Impedance Analysis
Phase angle Measured at baseline and preoperatively Measurement of phase angle, using Bioelectrical Impedance Analysis
Prehabilitation cost-effectiveness Measured at 1 year postoperatively Measurement of prehabilitation cost-effectiveness using data from SF6D, prehabilitation costs and hospitalization related costs.
Trial Locations
- Locations (1)
MUHC-RIMUHC Royal Victoria Hospital
🇨🇦Montréal, Quebec, Canada